Degarelix
| CAS No. | 214766-78-6 | Cat. No. | BCP20973 |
| Name | Degarelix | ||
| Synonyms | FE200486; FE-200486; FE 200486; ASP3550; ASP-3550; ASP 3550; | ||
| Formula | C82H103ClN18O16 | M. Wt | 1632.28 |
| Description | Degarelix, also known as FE-200486 and ASP-3550, is a long-acting, synthetic peptide with gonadotrophin-releasing hormone (GnRH) antagonistic properties. Degarelix targets and blocks GnRH receptors located on the surfaces of gonadotroph cells in the anterior pituitary, thereby reducing secretion of luteinizing hormone (LH) by pituitary gonadotroph cells and so decreasing testosterone production by interstitial (Leydig) cells in the testes. Degarelix acetate was approved in 2008. | ||
| Pathways | GPCR/G Protein | ||
| Targets | GnRH Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.